ArticleCancer research and treatment2024

Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better Than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.